Product Name: | Dalazatide TFA |
Catalog Number: | M31052 |
Formula: | C186H297F3N57PS7 |
Molecular Weight: | 4556.1 |
Form: | Solid |
Solubility: | Water |
Storage: | Store at ≤ -20°C, dry, sealed |
QC Standard: | ≥99.0% |
Description: | Dalazatide (ShK-186) TFA is a specific Kv1.3 potassium channel peptide inhibitor. Dalazatide TFA can be used in the study of autoimmune diseases such as multiple sclerosis (MS), lupus erythematosus, psoriasis, rheumatoid arthritis, type 1 diabetes and inflammatory bowel disease. |
Stability and Solubility Advice: | Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide. We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials and used within 1 month. Avoid repeated freeze and thaw cycles. Storage conditions for some special products should refer to their storage details. |